Inomata M, Hayashi M, Shumiya S, Kawashima S, Ito Y
Department of Protein Biochemistry, Tokyo Metropolitan Institute of Gerontology, Tokyo, Itabashi-ku, Japan.
Curr Eye Res. 2001 Oct;23(4):307-11. doi: 10.1076/ceyr.23.4.307.5455.
Our previous results showed that the oral administration of aminoguanidine (AG), an inhibitor of inducible nitric oxide synthase (iNOS), strongly suppresses lens opacification in Shumiya cataract rat (SCR). Therefore, we examine whether iNOS is upregulated and involved in cataract formation in SCR.
The expressions of iNOS mRNA and iNOS protein in SCR lenses were examined by RT-PCR and Western blotting, respectively. Calpain-mediated alphaB-crystallin proteolysis was analyzed by Western blotting using antibody specific to the calpain-generated fragment of alphaB-crystallin. Lens opacification was analyzed using computerized image analysis software connected to the Anterior Eye Segment Analysis System (EAS-1000, Nidek). Calcium contents in lenses were measured by atomic absorption spectrophotometry.
High levels of iNOS mRNA and iNOS protein are expressed in cataractous lenses compared with normal lenses. The increases in their expression are markedly suppressed by the oral administration of AG, which acts to prevent lens opacification. The induction of iNOS protein is observed before the elevation in calcium content and the acceleration of calpain-mediated proteolysis, both of which are closely related to the development of lens opacification.
These findings strongly suggest that iNOS is involved in cataract formation in SCR. The induction of iNOS occurs prior to the elevation of calcium content and its induction is inhibited by AG-treatment. Considering our previous result that the elevation of calcium content is also prevented by AG-treatment, it is conceivable that upregulation of iNOS causes calcium influx into lens cells and the subsequent activation of calpain.
我们之前的研究结果表明,口服氨基胍(AG),一种诱导型一氧化氮合酶(iNOS)抑制剂,能强烈抑制舒米亚白内障大鼠(SCR)的晶状体混浊。因此,我们研究iNOS是否上调并参与SCR的白内障形成。
分别通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法检测SCR晶状体中iNOS mRNA和iNOS蛋白的表达。使用针对钙蛋白酶产生的αB-晶状体蛋白片段的特异性抗体,通过蛋白质免疫印迹法分析钙蛋白酶介导的αB-晶状体蛋白的蛋白水解。使用连接到眼前节分析系统(EAS-1000,尼德克)的计算机图像分析软件分析晶状体混浊情况。通过原子吸收分光光度法测量晶状体中的钙含量。
与正常晶状体相比,白内障晶状体中iNOS mRNA和iNOS蛋白表达水平较高。口服AG可显著抑制它们表达的增加,AG可防止晶状体混浊。在钙含量升高和钙蛋白酶介导的蛋白水解加速之前观察到iNOS蛋白的诱导,这两者均与晶状体混浊的发展密切相关。
这些发现强烈表明iNOS参与了SCR的白内障形成。iNOS的诱导发生在钙含量升高之前,并且其诱导受到AG处理的抑制。考虑到我们之前的结果,即AG处理也可防止钙含量升高,可以推测iNOS的上调导致钙流入晶状体细胞并随后激活钙蛋白酶。